| |
| |
|
| Insider
Information: |
Canute Scott A |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
285,409 |
|
|
Indirect Shares
|
24,034 |
|
|
| Direct
Value |
$18,625,306 |
|
|
|
Indirect Value
|
$17,629,179 |
|
|
| Total
Shares |
309,443 |
|
|
| Total
Value |
$36,254,486 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
President, Mfg. Operat... |
2007-02-01 |
25,367 |
2007-02-01 |
24,034 |
Premium* |
|
|
Genzyme Corp |
GENZ |
Executive VP |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
|
Outlook Therapeutics Inc |
OTLK |
Director |
2016-11-28 |
246,342 |
|
0 |
Premium* |
|
|
Immunomedics Inc |
IMMU |
Director |
2020-10-23 |
0 |
2018-04-02 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2019-06-06 |
13,700 |
2019-06-06 |
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2020-06-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-11-19 |
4 |
D |
$8.50 |
$76,500 |
D/D |
(9,000) |
0 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
9,000 |
0 |
- |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2020-10-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,516) |
0 |
0 |
- |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,718 |
17,234 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
4,500 |
0 |
- |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2019-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
9,667 |
13,516 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
13,700 |
0 |
- |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,849 |
3,849 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Director |
– • – |
2016-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
57,408 |
246,342 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
|
– • – |
2016-11-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,971 |
188,934 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
|
– • – |
2016-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
57,971 |
0 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Director |
– • – |
2016-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
58,500 |
130,963 |
0 |
- |
|
| OTLK |
Outlook Therapeutics Inc |
Director |
– • – |
2016-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
72,463 |
|
- |
|
| OTLK |
Outlook Therapeutics Inc |
Director |
– • – |
2016-05-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
57,971 |
|
- |
|
| GENZ |
Genzyme Corp |
Executive VP |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,850,000 |
D/D |
(25,000) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Executive VP |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, Mfg. Operations |
• – – |
2007-02-01 |
4 |
D |
$54.12 |
$198,512 |
D/D |
(3,668) |
25,367 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, Mfg. Operations |
• – – |
2007-01-17 |
4 |
A |
$52.86 |
$917,385 |
D/D |
17,355 |
29,035 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, Mfg. Operations |
• – – |
2006-06-13 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,293 |
18,078 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
officerTitle |
• – – |
2006-01-20 |
4 |
A |
$57.04 |
$666,227 |
D/D |
11,680 |
11,680 |
|
- |
|
| LLY |
Eli Lilly & Co |
President, Mfg. Operations |
• – – |
2005-08-29 |
5 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
0 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, Mfg. Operations |
• – – |
2005-08-29 |
5 |
GA |
$0.00 |
$0 |
I/I |
6,000 |
19,371 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President, Mfg. Operations |
• – – |
2005-08-16 |
4 |
OE |
$23.40 |
$162,600 |
D/D |
6,000 |
6,753 |
|
- |
|
| LLY |
Eli Lilly & Co |
President, Mfg. Operations |
• – – |
2005-08-15 |
4 |
S |
$53.30 |
$170,564 |
D/D |
(3,200) |
753 |
|
- |
|
| LLY |
Eli Lilly & Co |
President, Mfg. Operations |
• – – |
2005-08-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,091 |
13,948 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
